Stay updated with breaking news from Barbara buttin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Joshua G. Cohen, MD, FACOG, FACS, expands on the role of PARP inhibitors in the recurrent and up-front settings in ovarian cancer, and the clinical significance of the RUBY and NY-GY018 trials in endometrial cancer. ....